Batch-linked records

Documentation Status

SELECT A STRENGTH
Selected strength
Not selected
Batch
Pending selection
Laboratory
Published with report
Analysis date
Published with report
View laboratory details

LaboratoryPublished with report

Select a labeled strength to confirm whether released batch documentation is available.

Tesamorelin

$125.00

Tesamorelin is cataloged as growth-hormone-releasing-hormone analogue research peptide in 10 MG. Batch-specific analytical documentation is displayed only after product, variation, and physical-lot review. For laboratory research use only.

For laboratory research use only Not for human or veterinary use. Review batch documentation before ordering.

Description

Tesamorelin | Product Description

Tesamorelin | Introduction

Tesamorelin is a growth-hormone-releasing-hormone analogue used in published research involving GHRH-receptor and downstream signaling pathways. This catalog item is for laboratory research only. It is not intended for diagnostic, therapeutic, human, or veterinary use.

  • GHRH-receptor signaling models
  • Growth-factor pathway research
  • Peptide identity and stability analysis

At a glance: Growth-hormone-releasing-hormone analogue research peptide · 10 MG · Batch-specific documentation

Tesamorelin | Molecular Identity & Composition
Material name Tesamorelin
Research classification Growth-hormone-releasing-hormone analogue research peptide
Composition Tesamorelin research peptide
Physical form Lyophilized research material
Catalog structure Parent product page with variation-specific SKUs
Purity and identity Batch-specific results only; review the Third-Party COA tab when released
Tesamorelin | Available Formats

The currently cataloged labeled formats are:

  • 10 MG

Each purchasable variation retains its own SKU, inventory status, and batch-documentation relationship. Select the required variation above before adding the material to the cart.

Ntegrity Quality & Documentation

Ntegrity Labs treats analytical evidence as batch-specific. A product-level badge does not replace the underlying laboratory report. When approved documentation is available, the Third-Party COA tab identifies the relevant material, batch, laboratory, methods, test date, and reported results.

  • No purity claim is applied across unrelated batches.
  • Third-party and partner reports retain their original laboratory and customer provenance.
  • A report is published only after its product, variation, and physical batch relationship has been reviewed.
Category Overview | Growth Factor Synthesis Research

This category covers materials studied in GHRH-receptor signaling, secretagogue pathways, and downstream growth-factor response models.

Category placement describes research context only. It is not a statement of clinical performance, safety, or intended therapeutic use.

Tesamorelin | Research Context & Applications

Published studies describe tesamorelin as a GHRH analogue. Research may examine receptor-pathway activation, comparative analog behavior, and analytical characterization. Clinical publications do not establish an intended use for this catalog material.

Published studies describe the referenced compound or class. They do not establish an intended use for the Ntegrity Labs research material sold on this page.

Research Use Disclaimer

This material is intended exclusively for laboratory research and analytical work. It is not for human or veterinary use and is not intended for diagnosis, treatment, cure, mitigation, or prevention of disease. Purchasers are responsible for lawful acquisition, qualified handling, appropriate storage, and use within suitable research facilities.

Tesamorelin batch and COA registry

Use this page to verify the labeled strength, batch or lot identifier, testing laboratory, and current third-party report before ordering or beginning laboratory work.

StrengthStatusBatch / lotTest dateLaboratoryResultsReport
10 MG Current TESA-061424-10 2026-07-20 SteriGenix Analytical, LLC Identity confirmed (LC-MS) View COA